FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: January 31, 2005 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person * van der Meer Pieter   2. Issuer Name and Ticker or Trading Symbol BG Medicine, Inc. [BGMD] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director __X__ 10% Owner _____ Officer (give title below) _____ Other (specify below) (Last) (First) (Middle) C/O GILDE HEALTHCARE PARTNERS, NEWTONLAAN 91 3584 BP 3. Date of Earliest Transaction (Month/Day/Year) 04/17/2012 (Street) UTRECHT, P7  4. If Amendment, Date Original Filed(Month/Day/Year) 6. Individual or Joint/Group Filing(Check Applicable Line) ___ Form filed by One Reporting Person _X_ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 04/17/2012   S   200,000 D $ 6.6 1,635,432 I By Gilde Europe Food & Agribusiness Fund B.V. (1)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 3)

2. Conversion or Exercise Price of Derivative Security

3. Transaction Date (Month/Day/Year)

3A. Deemed Execution Date, if any (Month/Day/Year)

4. Transaction Code (Instr. 8)

5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5)

6. Date Exercisable and Expiration Date (Month/Day/Year)

7. Title and Amount of Underlying Securities (Instr. 3 and 4)

8. Price of Derivative Security (Instr. 5)

9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)

10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)

11. Nature of Indirect Beneficial Ownership (Instr. 4)

Code

V

(A)

(D)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
van der Meer Pieter C/O GILDE HEALTHCARE PARTNERS NEWTONLAAN 91 3584 BP UTRECHT, P7		X
Gilde Europe Food & Agribusiness Fund B.V. C/O GILDE HEALTHCARE PARTNERS NEWTONLAAN 91 3584 BP UTRECHT, P7		X
Gilde Agribusiness Management B.V. C/O GILDE HEALTHCARE PARTNERS NEWTONLAAN 91 3584 BP UTRECHT, P7		X
Gilde Healthcare Holding B.V. C/O GILDE HEALTHCARE PARTNERS NEWTONLAAN 91 3584 BP UTRECHT, P7		X
de Graaf Edwin C/O GILDE HEALTHCARE PARTNERS NEWTONLAAN 91 3584 BP UTRECHT, P7		X
Perret Marc Olivier C/O GILDE HEALTHCARE PARTNERS NEWTONLAAN 91 3584 BP UTRECHT, P7		X
Gilde Europe Food & Agribusiness Partners II C.V. C/O GILDE HEALTHCARE PARTNERS NEWTONLAAN 91 3584 BP UTRECHT, P7		X

Signatures

/s/ Pieter van der Meer		04/19/2012
**Signature of Reporting Person		Date
/s/ Edwin de Graaf		04/19/2012
**Signature of Reporting Person		Date
/s/ Marc Olivier Perret		04/19/2012
**Signature of Reporting Person		Date
/s/ Pieter van der Meer, Partner, Gilde Europe Food & Agribusiness Fund B.V.		04/19/2012
**Signature of Reporting Person		Date
/s/ Pieter van der Meer, Partner, Gilde Agribusiness Management B.V.		04/19/2012
**Signature of Reporting Person		Date
/s/ Pieter van der Meer, Partner, Gilde Healthcare Holding B.V.		04/19/2012
**Signature of Reporting Person		Date
/s/ Pieter van der Meer, Partner, Gilde Europe Food & Agribusiness Partners II C.V.		04/19/2012
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	The manager of Gilde Europe Food & Agribusiness Fund B.V. is Gilde Agribusiness Management B.V., which is indirectly owned by three managing partners, Pieter van der Meer, Edwin de Graaf and Marc Olivier Perret, through a holding entity, Gilde Healthcare Holding B.V. Gilde Healthcare Holding B.V. is owned in equal thirds by the three managing partners. Gilde Europe Food & Agribusiness Partners II C.V. and Gilde Agribusiness Management B.V. respectively have a 15% and 5% carried interest in Gilde Europe Food & Agribusiness Fund B.V. Pieter van der Meer, Edwin de Graaf and Marc Olivier Perret together have a controlling interest in Gilde Europe Food & Agribusiness Partners II C.V. Each of Pieter van der Meer, Edwin de Graaf, and Marc Olivier Perret disclaim beneficial ownership of the securities except to the extent of his pecuniary interest therein.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.